adrenergic receptors
play

1B 1B -Adrenoceptor phosphorylation. Adrenoceptor phosphorylation. Roles(s) of autocrine/ paracrine Roles(s) of autocrine/ paracrine Communication? Communication? J. Adolfo Garca J. Adolfo Garca- -Sinz Sinz Instituto de

0 downloads 5 Views 1,57 MB Size Report
  1. α 1B 1B -Adrenoceptor phosphorylation. Adrenoceptor phosphorylation. Roles(s) of autocrine/ paracrine Roles(s) of autocrine/ paracrine Communication? Communication? J. Adolfo García J. Adolfo García- -Sáinz Sáinz Instituto de Fisiología Celula Instituto de Fisiología Celula UNAM UNAM

  2. α 1D α 2C β 3 α 1B α 2B β 2 α 1A α 2A β 1 1 α 2 α β ADRENERGIC RECEPTORS

  3. Extracellular S N S S T Q N P G T F N A D K L E G W Q A P A S T N H G T D L D P N M T Amino-terminus L P Q L D D D K E C A 293 � E or I V W V L G R G V T N Constitutive activity Y I S T L K P P R P T G F A A E C L P F D I E S V G V E L D I W E K W P F Y L S G A V F A L V L G T A S F A A V D G L L P A L F S L P L K V V F Plasma A F I P L V V L C G I S S L G I F F W L G I V T S L F A I T F S L C T A S S F Y I P L W C Y F N S membrane L V W V G N L L D I L S P L A L I F C L N V S L L I L V I A I A L L C A I V I L V M G V V P I I Y A L I L S V N V I S I D M Y C I G L P C S T S K A F A R R V K Y K C N R H L R T P T N Y E F K R A G α 14 coupling sites Y A R I A R G I K T V F VA R L E A G V M K T T K N V K R M E D 142 � A or T Y S L Q Y P T L E R M R I S F N K S H I R L T L E K Constitutive activity S N L F S G α q coupling site H G ED K C V K L F T L Q S S T K A K G H N P R S S I A C R S Q S S K R S R E L G G R T W P R Y T Y A C A G L R R R R R R R R G Phosphorylation sites D S PKC � S L D D S G S C M S G S Q R T L P S A S P S P G Y L G R G A Q P P L E L GRK � S C A E G L L K F T F L P G S D L R G R R G P P E P L S L L A G S K W E P Y P E S P G T E G D A S N G G C D A T T D L A N G Q P G F K S N M P L A P G H Carboxyl-terminus Intracellular F

  4. Desensitization Desensitization 100 EFFECT 75 50 25 0 0 1 2 3 4 5 [DRUG]

  5. Homologous desensitization Homologous desensitization

  6. Agonist Agonist PI3K PL-C PDK-1 PKC ? DG Heterologous desensitization Heterologous desensitization

  7. Does LPA induce Does LPA induce α 1B 1B -AR phosphorylation? AR phosphorylation? How does it take place? How does it take place?

  8. LPA-R AC α PLC γ γ β G i AMPc IP3 ions DG PI3K

  9. PTX μ g/ml LOG [ LPA ] M 0.0 - 10 - 9 - 8 - 7 - 6 - 5 0.3 B NE LPA TPA α 1b -AR PHOSPHORYLATION CONTROL PT X 250 α 1b -AR PHOSPHORYLATION 300 (% OF BASAL) 200 (% OF BASAL) 200 150 C ONT STAU * 100 GEN 100 -10 -8 -6 -4 W OR T NE LPA TPA LOG [ LPA ] M B NE L PA NE LP A 300 α 1b -AR PHOSPHORYLATION (% OF BASAL) 200 * * 100 CONT STAU GEN WORT

  10. α 1B -AR LPA-R α PDK1 γ γ β ? PI3K G i ? PKC

  11. EGF-R α 1B -AR HB-EGF LPA-R MP α γ γ β PDK PI3K G i PKC

  12. Is the EFG receptor role general ? Is the EFG receptor role general ?

  13. NA +AG α 1B -Adrenoceptor Phosphorylation NA (% of basal) - Log [Noradrenaline] M 100 125 150 175 B -9 -9 PMA +AG PMA -8 α 1B -Adrenoceptor Phosphorylation -7 (% of basal) -7 100 150 200 250 -6 -5 B -5 - Log [PMA] M -9 -9 α 1B -Adrenoceptor Phosphorylation Et-1 +AG -8 (% of basal) -8 Et-1 -7 100 125 150 175 200 225 -7 - Log [Endothelin-1] M -6 -6 B -10 -9 -10 -9 -8 -8 -7 -7

  14. α 1B -Adrenoceptor Phosphorylation (% of basal) 100 150 200 EGF receptor autophosphorylation Basal Basal Basal Et Et Et-1 * Et +AG ** +AG + BB-94 +BB ** +BB +aHB-EGF +WT +aHB-EGF ** EGF +WT ** EGF + BB -94

  15. α 1B -Adrenoceptor Phosphorylation (% of basal) EGF receptor autophosphorylation 100 150 200 Basal Basal Basal Basal + BB-94 * NA NA NA +AG ** ** ** +AG NA +BB +BB + BB-94 +aHB-EGF +WT +aHB-EGF EGF +WT EGF + BB-94

  16. Model for α 1B Model for 1B -AR homologous desensitization AR homologous desensitization α 1B -AR HB-EGF EGF-R MP DG α γ γ β PI3K GRK PDK PKC

  17. Does TRK activation induce Does TRK activation induce α 1D 1D -AR phosphorylation and AR phosphorylation and desensitization? desensitization?

  18. Δ [Ca 2+ ]i [nM] 2000 NA 1000 0 0 25 50 75 100 Time (seconds) + INS Δ [Ca 2+ ]i [nM] + IGF-I Δ [Ca 2+ ]i [nM] 2000 NA 2000 NA 1000 1000 0 0 0 25 50 75 100 0 25 50 75 100 Time (seconds) Time (seconds) + EGF Δ [Ca 2+ ]i [nM] + PDGF Δ [Ca 2+ ]i [nM] NA 2000 NA 2000 1000 1000 0 0 0 25 50 75 100 0 25 50 75 100 Time (seconds) Time (seconds)

  19. IGF- I 0 1 3 10 30 100 0 0.01 0.1 1.0 10 100 α 1D -Adrenoceptor phosphorylation α 1D -Adrenoceptor phosphorylation 250 250 ( % of basal) ( % of basal) 200 200 150 150 100 100 0 1 10 100 0 0.01 1.0 100 Insulin (ng/ml) IGF -I (ng/ml) 0 0.01 0.1 1.0 10 100 0 0.01 0.1 1.0 10 100 α 1D -Adrenoceptor phosphorylation α 1D -Adrenoceptor phosphorylation 250 250 ( % of basal) ( % of basal) 200 200 150 150 100 100 0 0.01 1.0 100 0 0.01 1.0 100 PDGF (ng/ml) EGF (ng/ml)

  20. Patricia Casas Patricia Casas- -González González M. Teresa Romero M. Teresa Romero- -Ávila Ávila Tzindilú Molina Tzindilú Molina- -Muñoz Muñoz Ekaterina Rodríguez Ekaterina Rodríguez Ekaterina Kalashnikova Ekaterina Kalashnikova Erika Calvo Erika Calvo Guadalupe Reyes Guadalupe Reyes- -Cruz Cruz- - CINVESTAV CINVESTAV

Recommend Documents


sensory receptors
Sensory receptors Unencapsulated

Sensory receptors Unencapsulated receptors Encapsulated receptors Have

2 adrenergic receptor
2 -ADRENERGIC RECEPTOR AND THE

GENETIC VARIATION IN THE 2 -ADRENERGIC RECEPTOR AND THE CIRCULATION Niels V.

receptors and effectors
RECEPTORS AND EFFECTORS ESTIMULI AND

RECEPTORS AND EFFECTORS ESTIMULI AND RESPONSES SENSORY RECEPTORS They are

immature beta adrenergic over activity can cause rage
IMMATURE BETA-ADRENERGIC

IMMATURE BETA-ADRENERGIC OVER-ACTIVITY CAN CAUSE RAGE BEHAVIOR IN CHILDREN

1
1 Classes of Receptors Classes of

HAPTICS Haptic Perception & Haptic Perception & Human Response to

special senses
Special Senses Special sensory

Special Senses Special sensory receptors Distinct, localized receptor cells

sweet taste receptors modulate glucose absorption
Sweet Taste Receptors Modulate Glucose

Sweet Taste Receptors Modulate Glucose Absorption George A Kyriazis Assistant

inhaled drugs
Inhaled Drugs Metered Dose Inhalers

Inhaled Drugs Metered Dose Inhalers (MDIs) Spacer Respiratory Pharmacology

51a a amp p nervous system autonomic nervous system and
51a A&P: Nervous System -

51a A&P: Nervous System - Autonomic Nervous System and Sensory Receptors

studies on the use of naphtyridine derivatives as
STUDIES ON THE USE OF NAPHTYRIDINE

[c003] STUDIES ON THE USE OF NAPHTYRIDINE DERIVATIVES AS EFFECTIVE RECEPTORS

healey als platform trial
HEALEY ALS Platform Trial Sabrina

HEALEY ALS Platform Trial Sabrina Paganoni, MD, PhD Ben Saville, PhD Jinsy

ap1189 a new medicine to treat inflammatory diseases
AP1189 - A new medicine to treat

AP1189 - A new medicine to treat inflammatory diseases Thomas Jonassen, CSO

syncona capital
Syncona Capital Markets Day February

Syncona Capital Markets Day February 2020 synconaltd.com Image Freeline

5 30 18
5/30/18 Medical Cannabis: Operational

5/30/18 Medical Cannabis: Operational Issues (Training, Workforce,

what can researchers contribute to measuring impact
What can researchers contribute to

What can researchers contribute to measuring impact? Agnes Kant,

asd sd work orking grou oup mole olecular tar arget
ASD SD Work orking Grou oup Mole

ASD SD Work orking Grou oup Mole olecular Tar arget Literature Review

corporate presentation
Corporate Presentation H.C. Wainwright

Corporate Presentation H.C. Wainwright & Co. 21 st Annual Global

drive tumor infiltrating t cell expansion in
drive tumor-infiltrating T-cell

TLR9 agonist harnesses innate immunity to drive tumor-infiltrating T-cell

corporate
CORPORATE PRESENTATION I. CORPORATE

OCTOBER 2019 CORPORATE PRESENTATION I. CORPORATE HIGHLIGHTS II.

to fight cancer
TO FIGHT CANCER 4Q 2019 11 March 2020

ACTIVATING THE PATIENTS IMMUNE SYSTEM TO FIGHT CANCER 4Q 2019 11 March 2020

annual general meeting
ANNUAL GENERAL MEETING MAY 29, 2020

ANNUAL GENERAL MEETING MAY 29, 2020 MANAGEMENT PRESENTATION LISTED EURONEXT

the cre luc reporter m ouse m odel
The CRE Luc Reporter M ouse M odel A

The CRE Luc Reporter M ouse M odel A transgenic bioimaging mouse model to